According to Philly.com, the Food and Drug Administration formed a task force to study its regulation of the body part industry.

The FDA task force will look at the effectiveness of rules implemented just last year, prior to the two most recent scandals. In Philadelphia, a funeral home was under investigation for its ties to New Jersey-based Biomedical Tissue Services and a ring of more than 30 funeral homes that allegedly harvested body parts - many were diseased - without the consent of the donors or their families.

In August 2006, the FDA shut down another company -- Donor Referral Services of Raleigh, N.C., saying the company had serious deficiencies in processing, screening, and record-keeping. The FDA said the records for at least five donors did not match their death certificates which leads one to believe that the tissue is not as safe as represented.